ReviewDrug development research2019
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.
Yang Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it